Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Molecular dynamics at the receptor level of immunodominant myelin oligodendrocyte glycoprotein 35-55 epitope implicated in multiple sclerosis

Yannakakis, Mary Patricia, Tzoupis, Haralambos, Michailidou, Elena, Mantzourani, Efthymia, Simal, Carmen and Tselios, Theodore 2016. Molecular dynamics at the receptor level of immunodominant myelin oligodendrocyte glycoprotein 35-55 epitope implicated in multiple sclerosis. Journal of Molecular Graphics and Modelling 68 , pp. 78-86. 10.1016/j.jmgm.2016.06.005

[img]
Preview
PDF - Accepted Post-Print Version
Download (1MB) | Preview

Abstract

Multiple Sclerosis (MS) is a common autoimmune disease whereby myelin is destroyed by the immune system. The disease is triggered by the stimulation of encephalitogenic T-cells via the formation of a trimolecular complex between the Human Leukocyte Antigen (HLA), an immunodominant epitope of myelin proteins and T-cell Receptor (TCR). Myelin Oligodendrocyte Glycoprotein (MOG) is located on the external surface of myelin and has been implicated in MS induction. The immunodominant 35–55 epitope of MOG is widely used for in vivo biological evaluation and immunological studies that are related with chronic Experimental Autoimmune Encephalomyelitis (EAE, animal model of MS), inflammatory diseases and MS. In this report, Molecular Dynamics (MD) simulations were used to explore the interactions of MOG35–55 at the receptor level. A detailed mapping of the developed interactions during the creation of the trimolecular complex is reported. This is the first attempt to gain an understanding of the molecular recognition of the MOG35–55 epitope by the HLA and TCR receptors. During the formation of the trimolecular complex, the residues Arg41 and Arg46 of MOG35–55 have been confirmed to serve as TCR anchors while Tyr40 interacts with HLA. The present structural findings indicate that the Arg at positions 41 and 46 is a key residue for the stimulation of the encephalitogenic T-cells.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Additional Information: This journal has an embargo period of 24 months.
Publisher: Elsevier
ISSN: 1093-3263
Date of First Compliant Deposit: 28 June 2016
Date of Acceptance: 10 June 2016
Last Modified: 12 Jan 2018 00:31
URI: http://orca-mwe.cf.ac.uk/id/eprint/92191

Citation Data

Cited 6 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics